While GLP-1 medications dont directly change female sex hormones, rapid weight loss and improved insulin sensitivity can indirectly trigger hormonal shift, leading to menstrual changes, mood or energy fluctuations, and considerations for bone, muscle, and mental health
June 2025: The FDA approved an updated Mounjaro label warning of acute kidney injury in some patients
The similar viewpoints were also supported by other critical reviews and clinical trials (5558), and inferred that GLP-1RA could be considered in patients at a high risk of, or with established cardiovascular diseases to improve the prognosis of cardiovascular events (especially nonfatal stroke), whilst SGLT2i could be recommended for patients with heart failure or chronic kidney diseases
Figure 4 Kinetic analyses showed that SsTyrA a Wt enzyme did not accept prephenate and had a K m for arogenate of 901 M (Table 1), which is substantially higher than previously reported plant and microbial TyrA enzymes (Rippert and Matringe, 2002
Supplements (and Superfoods) Looking to go a step further